Related Experiment Videos
Managing chemotherapy-induced nausea and vomiting
Professional Nurse (London, England)
|November 1, 1993
Summary
Nausea and vomiting significantly impact patient quality of life. The 5-HT3 antagonists offer an effective and well-tolerated pharmacological approach to managing emesis, improving patient outcomes.
Area of Science:
- Oncology
- Pharmacology
- Patient Care
Background:
- Nausea and vomiting (emesis) are debilitating side-effects impacting patient quality of life.
- Existing nursing, psychological, and pharmacological interventions offer partial control of emesis.
Purpose of the Study:
- To evaluate the efficacy and tolerability of 5-HT3 antagonists in managing nausea and vomiting.
Main Methods:
- Review of nursing, psychological, and pharmacological measures.
- Assessment of conventional anti-emetics.
- Evaluation of 5-HT3 antagonists.
Main Results:
- Conventional anti-emetics provide some emesis control.
- 5-HT3 antagonists demonstrate significant effectiveness.
- 5-HT3 antagonists are well-tolerated by patients.
Conclusions:
- 5-HT3 antagonists represent a valuable therapeutic option for managing chemotherapy-induced nausea and vomiting.
- Improved management of emesis enhances patient quality of life.